Close Menu
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
What's Hot

Human IPO: AI Lab is considering expanding its offering, sources say

November 18, 2026

“It’s hard to imagine the AI ​​industry without Jensen,” says OpenAI CEO Sam Altman.

November 18, 2026

3 things to watch when Trump, Xi and Putin meet in China

November 18, 2026
Facebook X (Twitter) Instagram
Smart Breaking News on AI, Business, Politics & Global Trends | WhistleBuzz
Facebook X (Twitter) Instagram
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
Smart Breaking News on AI, Business, Politics & Global Trends | WhistleBuzz
Home » Former Google DeepMind CEO Demis Hassabis’ AI company raises $5 billion
US

Former Google DeepMind CEO Demis Hassabis’ AI company raises $5 billion

Editor-In-ChiefBy Editor-In-ChiefNovember 17, 2026No Comments2 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email Copy Link
Follow Us
Google News Flipboard
Share
Facebook Twitter LinkedIn Pinterest Email


Google DeepMind’s Demis Hassabis speaks at the 2026 Google I/O Technology Developer Conference in Mountain View, California on May 19, 2026.

Carl Mondon | AFP | Getty Images

Isomorphic Labs, the artificial intelligence drug discovery startup founded by former Google DeepMind chief Demis Hassabis, has raised $5 billion in Series C funding, the company announced Tuesday.

Isomorphic’s round comes three and a half months after Hassabis stepped down as CEO of Google’s AI lab DeepMind, which he co-founded before being acquired by the big tech giant in 2014.

The round was co-led by Greenoaks and Sequoia Capital along with Andreessen Horowitz, with investments in: alphabetGoogle’s parent company. The new funding will help fund the design and development of new drugs using AI.

Investors are pouring record amounts of money into drug discovery startups in 2026 as companies look to take advantage of advances in AI. OpenAI and Anthropic are also investing in tools to develop new drugs using this technology.

Hassabis has been CEO of Isomorphic Labs since the startup spun out of DeepMind in 2021.

“When we founded Isomorphic, we believed that biology can be understood and modeled at the most fundamental molecular level, and that it can be fundamentally accelerated through AI,” Hassabis said.

“This round will enable us to accelerate our progress by building fundamental biological models, deepening our understanding of systemic disease, and advancing first treatment programs toward clinical trials that have a tangible impact on patients,” he added.

Isomorphic has built a proprietary drug design engine and treatment candidate pipeline designed using AI, which the company says will help deliver next-generation medicines.

Anthropic announced the launch of an AI drug discovery program in June, and OpenAI partnered with Novo Nordisk in April.

According to deal aggregation platform Dealroom, drug discovery startups will raise $23.2 billion in 2026, a record number.

Isomorphic last raised funding in May, raising $2.1 billion in Series B.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Editor-In-Chief
  • Website

Related Posts

Human IPO: AI Lab is considering expanding its offering, sources say

November 18, 2026

Kramer looks at the causes of the market decline and where stocks could go next

November 18, 2026

Booking Holdings creates new corporate division as AI reshapes travel

November 18, 2026
Add A Comment

Comments are closed.

News

President Donald Trump meets with ‘longtime friend’ Imelda Marcos during visit to Philippines Donald Trump News

By Editor-In-ChiefNovember 18, 2026

President Trump told Philippine President Marcos that his “parents know very well.”Published November 18, 2026November…

How the U.S. House of Representatives elects its leaders: A visual guide | 2026 U.S. Midterm Elections News

November 18, 2026

Why Democrat Mary Peltola’s Alaska Senate victory matters | 2026 US Midterm Election News

November 18, 2026
Top Trending

“It’s hard to imagine the AI ​​industry without Jensen,” says OpenAI CEO Sam Altman.

By Editor-In-ChiefNovember 18, 2026

The AI ​​industry is entering a new era, not just because of…

Sam Altman warns of a future where AI will make decisions instead of humans

By Editor-In-ChiefNovember 18, 2026

Sam Altman, co-founder and CEO of OpenAI, believes that people should be…

More banks say customers using AI agents are self-reliant even if hacked

By Editor-In-ChiefNovember 18, 2026

Citibank, the third-largest commercial bank in the U.S., changed its terms of…

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Welcome to WhistleBuzz.com (“we,” “our,” or “us”). Your privacy is important to us. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you visit our website https://whistlebuzz.com/ (the “Site”). Please read this policy carefully to understand our views and practices regarding your personal data and how we will treat it.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Facebook X (Twitter) Instagram Pinterest
  • Home
  • Advertise With Us
  • Contact US
  • DMCA Policy
  • Privacy Policy
  • Terms & Conditions
  • About US
© 2026 whistlebuzz. Designed by whistlebuzz.

Type above and press Enter to search. Press Esc to cancel.